Researchers at the University of California, Davis have developed non-hallucinogenic compounds with clinically relevant therapeutic efficacy that promote neural growth and plasticity.

Researchers at the University of California, Davis have developed a class of compounds intended for the treatment of neurodegenerative diseases such as Alzheimer's by inhibiting DYRK1A kinase and modulating 5-HT2Rs.

Researchers at the University of California, Davis have developed an integrated platform that combines AI-driven computational pathology with 3D-bioprinted, patient-derived tumor models to predict therapeutic response and enable functionally guided precision oncology.

Researchers at the University of California, Davis have developed an unmanned aerial vehicle (UVA) with foldable wings enabling vertical takeoff and landing (VTOL) combined with efficient motorless forward flight.

Researchers at the University of California, Davis and the USDA Agricultural Research Service (ARS) have developed RNAi-based compositions and methods that enhance miticide efficacy to control resistant Varroa destructor mites.

Researchers at the University of California, Davis have developed a protein-based composition and method that protects bioactive bacteria from thermal and osmotic stress during dehydration to maintain viability and shelf life.

Researchers at the University of California, Davis have developed a method that uses phenolic-rich agro-industrial residues to protect and stabilize beneficial microbes for improved shelf life and bioactivity.

Researchers at the University of California, Davis have developed an engineered thermostable lipase capable of efficiently degrading polyurethane plastics at elevated temperatures.